These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3666017)

  • 1. Effect of azapropazone and allopurinol on myocardial infarct size in rats.
    Montor SG; Thoolen MJ; Mackin WM; Timmermans PB
    Eur J Pharmacol; 1987 Aug; 140(2):203-7. PubMed ID: 3666017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of xanthine oxidase by azapropazone and 8-hydroxy-azapropazone.
    Jahn U; Thiele K
    Arzneimittelforschung; 1988 Apr; 38(4):507-8. PubMed ID: 3401265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent cardioprotection by azapropazone in a canine model of coronary artery thrombosis and thrombolysis.
    Knabb RM; Rasbach DE; Leamy AW; Fernando DP; Mackin WM; Boswell GA; Timmermans PB; Thoolen MJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):390-6. PubMed ID: 1711599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat neutrophil functional responses by azapropazone, an anti-gout drug.
    Mackin WM; Rakich SM; Marshall CL
    Biochem Pharmacol; 1986 Mar; 35(6):917-22. PubMed ID: 3006696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts.
    Akizuki S; Yoshida S; Chambers DE; Eddy LJ; Parmley LF; Yellon DM; Downey JM
    Cardiovasc Res; 1985 Nov; 19(11):686-92. PubMed ID: 3841027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs.
    Reimer KA; Jennings RB
    Circulation; 1985 May; 71(5):1069-75. PubMed ID: 3838707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of azapropazone on neutrophil migration in regional myocardial ischaemia/reperfusion injury in rabbits.
    Mousa SA; Brown R; Thoolen MJ; Smith RD
    Br J Pharmacol; 1990 Jun; 100(2):379-82. PubMed ID: 2165840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.
    Werns SW; Shea MJ; Mitsos SE; Dysko RC; Fantone JC; Schork MA; Abrams GD; Pitt B; Lucchesi BR
    Circulation; 1986 Mar; 73(3):518-24. PubMed ID: 3004782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of azapropazone on neutrophil migration in anaesthetized swine using a multichamber blister suction technique.
    Mousa SA; Brown R; Chan Y; Hsieh J; Smith RD
    Br J Pharmacol; 1990 Feb; 99(2):233-6. PubMed ID: 2158370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol therapy of ischemic heart disease with infarct extension.
    Parmley LF; Mufti AG; Downey JM
    Can J Cardiol; 1992 Apr; 8(3):280-6. PubMed ID: 1576562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the potential interactions between azapropazone and frusemide in man.
    Williamson PJ; Ene MD; Roberts CJ
    Br J Clin Pharmacol; 1984 Oct; 18(4):619-23. PubMed ID: 6487503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic evaluation of the effect of azapropazone on the gastric mucosa.
    Hradsky M; Bruce L
    Scand J Rheumatol; 1978; 7(1):31-2. PubMed ID: 675173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uricosuric action of azapropazone: dose-response and comparison with probenecid.
    Higgens CS; Scott JT
    Br J Clin Pharmacol; 1984 Sep; 18(3):439-43. PubMed ID: 6487482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine oxidase inhibition does not limit canine infarct size.
    Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
    Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azapropazone--a treatment for hyperuricaemia and gout?
    Gibson T; Simmonds HA; Armstrong RD; Fairbanks LD; Rodgers AV
    Br J Rheumatol; 1984 Feb; 23(1):44-51. PubMed ID: 6697072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic administration of allopurinol fails to exert any cardioprotective effect in rats submitted to permanent coronary artery ligation.
    Boucher F; de Leiris J
    Basic Res Cardiol; 1991; 86(3):227-35. PubMed ID: 1772386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of allopurinol, propranolol and methylprednisolone on infarct size in experimental myocardial infarction.
    Shatney CH; MacCarter DJ; Lillehei RC
    Am J Cardiol; 1976 Mar; 37(4):572-80. PubMed ID: 3960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.
    Geaney DP; Carver JG; Davies CL; Aronson JK
    Br J Clin Pharmacol; 1983 Jun; 15(6):727-34. PubMed ID: 6871071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts.
    Lee TM; Chen CC; Hsu YJ
    Free Radic Biol Med; 2011 Jun; 50(11):1461-70. PubMed ID: 21295134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The potentiating effects of azathioprine and azapropazone on the enzyme activity in experimental inflammation].
    Stojan B
    Z Rheumatol; 1976; 35(1-2):18-23. PubMed ID: 176844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.